Trial Profile
An observational, prospective cohort study of adalimumab in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics; Pharmacokinetics
- 09 Feb 2016 New trial record